M. Demir Et Al. , "Absorbed Dose Values After Radionuclide Therapy with LU-177 DOTA TATE in Patients with Neuroendocrine Tumor," Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , vol.40, Lyon, France, 2013
Demir, M. Et Al. 2013. Absorbed Dose Values After Radionuclide Therapy with LU-177 DOTA TATE in Patients with Neuroendocrine Tumor. Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , (Lyon, France).
Demir, M., Yeyin, N., Toklu, T., Uslu, L., Cavdar, I., & Kabasakal, L., (2013). Absorbed Dose Values After Radionuclide Therapy with LU-177 DOTA TATE in Patients with Neuroendocrine Tumor . Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, France
Demir, M. Et Al. "Absorbed Dose Values After Radionuclide Therapy with LU-177 DOTA TATE in Patients with Neuroendocrine Tumor," Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, France, 2013
Demir, M. Et Al. "Absorbed Dose Values After Radionuclide Therapy with LU-177 DOTA TATE in Patients with Neuroendocrine Tumor." Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Lyon, France, 2013
Demir, M. Et Al. (2013) . "Absorbed Dose Values After Radionuclide Therapy with LU-177 DOTA TATE in Patients with Neuroendocrine Tumor." Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Lyon, France.
@conferencepaper{conferencepaper, author={M. Demir Et Al. }, title={Absorbed Dose Values After Radionuclide Therapy with LU-177 DOTA TATE in Patients with Neuroendocrine Tumor}, congress name={Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)}, city={Lyon}, country={France}, year={2013}}